首页> 外文OA文献 >Development and Validation of a New Clinical Scale for Infants with Acute Respiratory Infection: The ReSVinet Scale
【2h】

Development and Validation of a New Clinical Scale for Infants with Acute Respiratory Infection: The ReSVinet Scale

机译:婴幼儿急性呼吸道感染新临床量表的开发和验证:ReSVinet量表

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Background and AimsA properly validated scoring system allowing objective categorization of infants with acute respiratory infections (ARIs), avoiding the need for in-person assessment and that could also be used by non-health professionals is currently not available. We aimed to develop a new clinical assessment scale meeting these specifications.MethodsWe designed a clinical scale (ReSVinet scale) based on seven parameters (feeding intolerance, medical intervention, respiratory difficulty, respiratory frequency, apnoea, general condition, fever) that were assigned different values (from 0 to 3) for a total of 20 points.170 children under two years of age with ARI were assessed independently by three pediatricians using this scale. Parents also evaluated their offspring with an adapted version of the scale in a subset of 61 cases. The scale was tested for internal consistency (Cronbach’s alpha), Pearson correlation coefficient for the items in the scale, inter-observer reliability (kappa index) and floor-ceiling effect.ResultsInternal consistency was good for all the observers, with the lowest Cronbach’s alpha being 0.72. There was a strong correlation between the investigators (r-value ranged 0.76–0.83) and also between the results obtained by the parents and the investigators(r = 0.73). Light’s kappa for the observations of the three investigators was 0.74. Weighted kappa in the group evaluated by the parents was 0.73. The final score was correlated with length of hospital stay, PICU admission and Wood-Downes Score.ConclusionsThe ReSVinet scale may be useful and reliable in the evaluation of infants with ARI, particularly acute bronchiolitis, even with data obtained from medical records and when employed by parents. Although further studies are necessary, ReSVinet scale already complies with more score validation criteria than the vast majority of the alternatives currently available and used in the clinical practice
机译:背景和目标目前尚无法获得经过正确验证的评分系统,该评分系统可以对急性呼吸道感染(ARI)的婴儿进行客观分类,从而避免了需要进行现场评估的情况,而且非医疗专业人员也可以使用该评估系统。我们旨在开发一种符合这些规范的新临床评估量表。方法我们根据七个参数(喂养不耐受,医疗干预,呼吸困难,呼吸频率,呼吸暂停,一般情况,发烧)设计了一个临床量表(ReSVinet量表)值(从0到3)共计20分。三名儿科医生使用此量表对170岁以下的ARI两岁以下儿童进行了独立评估。父母们还用61个案例的子集来评估他们的后代。测试了量表的内部一致性(Cronbach's alpha),量表中项目的皮尔逊相关系数,观察者间可靠性(kappa指数)和最低限度效果。结果内部一致性对所有观察者均良好,Cronbach'sα最低是0.72。研究者之间的相关性极强(r值介于0.76-0.83之间),父母与研究者之间的相关性也极强(r = 0.73)。三位调查人员的观察结果的Light的kappa为0.74。父母评估组中的加权κ为0.73。最终得分与住院时间,PICU入院时间和Wood-Downes得分相关。结论ReSVinet量表在评估ARI(特别是急性毛细支气管炎)婴儿方面可能是有用且可靠的,即使是从病历中获得的数据以及由父母。尽管有必要进行进一步的研究,但ReSVinet量表已经比目前临床实践中使用的绝大多数替代方法符合更多的评分验证标准。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号